» Articles » PMID: 32309426

The Effects of Preoperative Oral Carbohydrate on Frequency of T and NK Cells in Patients with Cervical Cancer Treated Using Neoadjuvant Chemotherapy and Surgery: A Prospective Cohort Study

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Apr 21
PMID 32309426
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Immune dysfunction can occur after neoadjuvant chemotherapy (NAC) and surgery for cancer. We investigated whether preoperative oral carbohydrate affected the postoperative percentages of T cells (CD4 and CD8) and natural killer (NK) cells in patients with cervical cancer treated with NAC and surgery.

Methods: This prospective cohort study enrolled consecutive patients with cervical cancer treated by radical hysterectomy with PLND at the Gynecologic Oncology Department of Fujian Provincial Cancer Hospital (China) between January 2018 and December 2018. Patients were divided into three groups according to the treatment method: NAC (two cycles, surgery 1 month later), NAC+CHO (chemotherapy and surgical methods same as with the NAC group but with 300 mL of oral carbohydrate administered 2 h before surgery), and non-NAC (surgery alone). Percentages of NK, CD3, CD4, and CD8 cells were evaluated by flow cytometry the day after the first admission, just before surgery, immediately after tracheal tube removal, and the day after surgery. This trial is registered with NCT03872635 at clinicaltrials.com.

Results: The final analysis included 77 patients (non-NAC group, = 26; NAC group, = 25; and NAC-CHO group, = 26). Baseline characteristics and preoperative NK, CD3, CD4, and CD8 cell percentages were similar between groups. Postoperatively, all groups exhibited reductions in NK, CD3, and CD4 cell percentages and increases in CD8 cell percentages (all < 0.05). The changes in NK, CD3, CD4, and CD8 cell percentages were attenuated in the NAC-CHO group ( < 0.05 vs. both other groups).

Conclusion: Preoperative oral carbohydrate can improve the postoperative populations of NK and T cells after the treatment of cervical cancer by NAC and surgery.

Citing Articles

Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia.

Xu X, Zhang J, Xing H, Han L, Li X, Wu P Sci Rep. 2024; 14(1):9040.

PMID: 38641637 PMC: 11031595. DOI: 10.1038/s41598-024-59493-7.


Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.

Zheng H, Jin S, Li T, Ying W, Ying B, Chen D Comput Struct Biotechnol J. 2021; 19:1863-1873.

PMID: 33841749 PMC: 8021501. DOI: 10.1016/j.csbj.2021.03.039.

References
1.
Rassy Carneiro S, Fagundes M, do Rosario P, Neves L, Souza G, Pinheiro M . Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon. PLoS One. 2017; 12(11):e0187579. PMC: 5690614. DOI: 10.1371/journal.pone.0187579. View

2.
Madani M, Alizadeh K, Ghazaee S, Zavarehee A, Abdi S, Shakerian F . Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury. Tex Heart Inst J. 2013; 40(4):410-7. PMC: 3783128. View

3.
Pace M, Williams J, Kurioka A, Gerry A, Jakobsen B, Klenerman P . Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. PLoS Pathog. 2016; 12(8):e1005782. PMC: 4986965. DOI: 10.1371/journal.ppat.1005782. View

4.
Gianotti L, Biffi R, Sandini M, Marrelli D, Vignali A, Caccialanza R . Preoperative Oral Carbohydrate Load Versus Placebo in Major Elective Abdominal Surgery (PROCY): A Randomized, Placebo-controlled, Multicenter, Phase III Trial. Ann Surg. 2017; 267(4):623-630. DOI: 10.1097/SLA.0000000000002325. View

5.
Fraser D, Thoen J, Reseland J, Forre O, Kjeldsen-Kragh J . Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol. 1999; 18(5):394-401. DOI: 10.1007/s100670050125. View